Salvage surgery for local recurrences after stereotactic ablative radiotherapy of colorectal pulmonary metastases.
SABR
colorectal pulmonary metastases
lung metastases
pulmonary metastasectomy
salvage metastasectomy
salvage surgery
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
06
07
2023
accepted:
08
07
2023
pubmed:
21
7
2023
medline:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Local control following stereotactic ablative radiotherapy (SABR) for patients with colorectal pulmonary metastases is reportedly lower than for metastases from other tumors. Such recurrences may still be amenable to salvage therapy. We describe our experience with salvage surgery in 17 patients. Patients who underwent salvage metastasectomy for a local recurrence following SABR for colorectal pulmonary metastases were identified from the surgical institutional databases of three Dutch major referral hospitals. Kaplan-Meier survival analysis was performed to determine survival. Seventeen patients underwent 20 salvage resections for local recurrence of colorectal pulmonary metastases. All patients had a progressive lesion on consecutive CT scans, with local uptake on Our experience with 20 salvage pulmonary metastasectomy procedures for local recurrences following SABR in colorectal cancer patients demonstrates that salvage resection is a feasible option with acceptable morbidity and good oncological outcome in a highly selected cohort.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1114-1120Informations de copyright
© 2023 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.
Références
Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol, 2023;34(1):10-32. doi:10.1016/j.annonc.2022.10.003
Mohamed F, Kallioinen M, Braun M, et al. Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance. Br J Surg. 2020;107(8):943-945. doi:10.1002/bjs.11609
Li J, Yuan Y, Yang F, et al. Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition). J Hematol Oncol. 2019;12(1):16. doi:10.1186/s13045-019-0702-0
Handy JR, Bremner RM, Crocenzi TS, et al. Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg. 2019;107(2):631-649. doi:10.1016/j.athoracsur.2018.10.028
Chen H, Louie AV, Boldt RG, Rodrigues GB, Palma DA, Senan S. Quality of life after stereotactic ablative radiotherapy for early-stage lung cancer: a systematic review. Clin Lung Cancer. 2016;17(5):e141-e149. doi:10.1016/j.cllc.2015.12.009
Nicosia L, Franceschini D, Perrone-Congedi F, et al. A multicenter Large retrospective database on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: the LaIT-SABR study. Radiother Oncol. 2022;166:92-99. doi:10.1016/j.radonc.2021.10.023
Cao C, Wang D, Tian DH, Wilson-Smith A, Huang J, Rimner A. A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases. J Thorac Dis. 2019;11(12):5187-5198. doi:10.21037/jtd.2019.12.12
Sheikh S, Chen H, Sahgal A, et al. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer. Radiother Oncol. 2022;167:187-194. doi:10.1016/j.radonc.2021.12.018
Chang JY, Mehran RJ, Feng L, et al. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. 2021;22(10):1448-1457. doi:10.1016/S1470-2045(21)00401-0
Yamamoto T, Niibe Y, Matsumoto Y, et al. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. J Radiat Res. 2020;61(6):935-944. doi:10.1093/jrr/rraa071
Klement RJ, Abbasi-Senger N, Adebahr S, et al. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC Cancer. 2019;19(1):173. doi:10.1186/s12885-019-5362-5
Nelson DB, Tayob N, Nguyen QN, et al. Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019;158(4):1234-1241. doi:10.1016/j.jtcvs.2019.02.133
Nelson DB, Tayob N, Mitchell KG, et al. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019;157(4):1648-1655. doi:10.1016/j.jtcvs.2018.10.156
Zerillo JA, Schouwenburg MG, van Bommel ACM, et al. An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer. JAMA Oncol. 2017;3(5):686. doi:10.1001/jamaoncol.2017.0417
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-196. doi:10.1097/SLA.0b013e3181b13ca2
Dickhoff C, Senan S, Dahele M. Radical-intent treatment of lung cancer after prior thoracic radiotherapy. J Thorac Oncol. 2017;12(3):e26-e27. doi:10.1016/j.jtho.2016.12.009
Chao HH, Berman AT, Simone CB, et al. Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung cancer. J Thorac Oncol. 2017;12(2):281-292. doi:10.1016/j.jtho.2016.10.018
Dickhoff C, Dahele M, Paul MA, et al. Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer. Lung Cancer. 2016;94:108-113. doi:10.1016/j.lungcan.2016.02.005
Antonoff MB, Correa AM, Sepesi B, et al. Salvage pulmonary resection after stereotactic body radiotherapy: a feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg. 2017;154(2):689-699. doi:10.1016/j.jtcvs.2017.03.142
Bograd AJ, Mann C, Gorden JA, et al. Salvage lung resections after definitive chemoradiotherapy: a safe and effective oncologic option. Ann Thorac Surg. 2020;110(4):1123-1130. doi:10.1016/j.athoracsur.2020.04.035
Schreiner W, Dudek W, Sirbu H. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival? Interact Cardiovasc Thorac Surg. 2015;21(5):682-684. doi:10.1093/icvts/ivv243
van Dorp M, Bousema JE, Torensma B, et al. Pulmonary metastasectomy with lymphadenectomy for colorectal pulmonary metastases: a systematic review. Eur J Surg Oncol. 2022;48(1):253-260. doi:10.1016/j.ejso.2021.09.020
Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38(25):2830-2838. doi:10.1200/JCO.20.00818
Milosevic M, Edwards J, Tsang D, et al. Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients-control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314-1324. doi:10.1111/codi.15113
Filippi AR, Guerrera F, Badellino S, et al. Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer. Clin Oncol. 2016;28(8):505-512. doi:10.1016/j.clon.2016.02.001
Lodeweges JE, Klinkenberg TJ, Ubbels JF, Groen HJM, Langendijk JA, Widder J. Long-term outcome of surgery or stereotactic radiotherapy for lung oligometastases. J Thorac Oncol. 2017;12(9):1442-1445. doi:10.1016/j.jtho.2017.05.015
Hamaji M, Mitsuyoshi T, Yoshizawa A, et al. Salvage pulmonary metastasectomy for local relapse after stereotactic body radiotherapy. Ann Thorac Surg. 2018;105(4):e165-e168. doi:10.1016/j.athoracsur.2017.11.003